Trials / Completed
CompletedNCT07386990
Cardioplegic Protection of the Heart
The Type of Cardioplegia and Cardiometabolic Impact - a Prospective Randomized Trial in Patients Undergoing CABG
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Region Skane · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study seek to compare two different solutions used to protect the heart during cardiac surgery. 40 adult patients planned for coronary artery bypass surgery with cardiopulmonary bypass machine assistance will be included in the study. Blood samples from the first 48 hours after surgery will be analyzed together with physical data, x-ray-results, ecg and general outcome after surgery.
Conditions
- Coronary Artery Bypass Graft (CABG)
- Cardioplegia
- Cardiopulmonary Bypass
- Perioperative Myocardial Injury
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Modified Buckberg cardioplegic solution | Study subjects randomized to this study group will receive Modified Buckberg cardioplegic solution during coronary artery bypass grafting operation. |
| DRUG | Modified St Thomas´ cardioplegic solution | Study subjects randomized to this study group will receive Modified St Thomas hospital´s cardioplegic solution during coronary artery bypass grafting operation. |
Timeline
- Start date
- 2021-06-15
- Primary completion
- 2021-11-18
- Completion
- 2025-04-29
- First posted
- 2026-02-04
- Last updated
- 2026-02-12
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT07386990. Inclusion in this directory is not an endorsement.